Glaucoma Specialists Design New Clinical Trial Model for Minimally Invasive Surgical Devices
On February 26, 2014 in Washington, DC, the United States Food and Drug Administration and the American Glaucoma Society co-sponsored the FDA – AGS Workshop Supporting Innovation for Safe and Effective Minimally Invasive Glaucoma Surgery (MIGS). The meeting provided a platform for a range of experts in the field of glaucoma surgery to discuss and attempt to define best practices for the development, assessment, safety and effectiveness of MIGS procedures.
Dr. Rohit Varma, professor and chair of the Illinois Eye and Ear Infirmary, made a significant contribution in the area of patient population identification suggesting that the current system for classifying patients in clinical trials of new glaucoma surgical procedures does not work well and that a new classification system be designed.
Please click here for a full report on the proceedings by Lea Radickpublished by Health News Daily on March 3, 2014.